Sana Biotechnology (SANA) Research & Development (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Research & Development data on file, last reported at $28.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 22.78% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $123.5 million (down 19.36% YoY), and the FY2025 full-year result was $132.0 million, down 38.81% from the prior year.
• Research & Development declined to $28.7 million in Q1 2026, from $34.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $76.7 million in Q3 2022 to a low of $1.9 million in Q4 2024.
• A 5-year average of $48.9 million and a median of $56.4 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development tumbled 89.05% in 2023 and surged 1738.11% in 2025, its largest moves.
• Tracing SANA's Research & Development over 5 years: stood at $63.9 million in 2022, then plunged by 89.05% to $7.0 million in 2023, then sank by 72.86% to $1.9 million in 2024, then surged by 1738.11% to $34.9 million in 2025, then declined by 17.77% to $28.7 million in 2026.
• Business Quant data shows SANA's Research & Development at $28.7 million in Q1 2026, $34.9 million in Q4 2025, and $30.1 million in Q3 2025.